KELLY SCHULTZ: Open Payments
NPI 1295505865 · KALISPELL, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $167 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $127 |
| ABBVIE INC. | 6 | $97 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
Products named: REXULTI, VRAYLAR, FANAPT, VERQUVO, INVEGA SUSTENNA, MOUNJARO, Cologuard Collection Kit, AIRSUPRA.
Industry payments across MT — which companies pay providers there.
